Third Rock Ventures II, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Third Rock Ventures II, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Third Rock Ventures II, L.P.. Third Rock Ventures II, L.P. is 10% Owner in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and 10% Owner in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Allena Pharmaceuticals, Inc. ($ALNA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Jounce Therapeutics, Inc. ($JNCE) and 10% Owner in Revolution Medicines, Inc. ($RVMD).
Latest Insider Trading Transactions of Third Rock Ventures II, L.P.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNA, BPMC, GBT, JNCE, MYOK, RVMD, SAGE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,500,000 | 0 | 4,447,829 | 5.9 M to 4.4 M (-25.22 %) |
| May 27 2021 | RVMD | Revolution Medicin ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 30.53 | 1,231,204 | 37,588,658 | 543,113 | 1.8 M to 543.1 K (-69.39 %) |
| May 27 2021 | RVMD | Revolution Medicin ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 30.93 | 135,000 | 4,175,550 | 1,774,317 | 1.9 M to 1.8 M (-7.07 %) |
| Mar 15 2021 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,250,000 | 0 | 6,500,349 | 7.8 M to 6.5 M (-16.13 %) |
| Nov 19 2020 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 7.25 | 15,000 | 108,773 | 9,215,349 | 9.2 M to 9.2 M (-0.16 %) |
| Nov 13 2020 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 9,230,349 | 10.2 M to 9.2 M (-9.77 %) |
| Mar 07 2018 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 885,104 | 2.9 M to 885.1 K (-69.32 %) |
| Dec 08 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 2,885,104 | 4.9 M to 2.9 M (-40.94 %) |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,629,630 | 0 | 0 | |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 6,122,448 | 0 | 0 | |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | P | 14.00 | 215,000 | 3,010,000 | 2,790,964 | 2.6 M to 2.8 M (+8.35 %) |
| Nov 06 2017 | ALNA | Allena Pharmaceuti ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 2,575,964 | 0 | 2,575,964 | 0 to 2.6 M |
| Sep 29 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 4,885,104 | 6.9 M to 4.9 M (-29.05 %) |
| Sep 27 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 43.00 | 400,000 | 17,200,000 | 6,885,104 | 7.3 M to 6.9 M (-5.49 %) |
| Sep 27 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 43.00 | 201,400 | 8,660,200 | 7,285,104 | 7.5 M to 7.3 M (-2.69 %) |
| Sep 12 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 44.25 | 20,000 | 885,080 | 57,651 | 77.7 K to 57.7 K (-25.76 %) |
| Sep 12 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 42.39 | 900 | 38,149 | 7,486,504 | 7.5 M to 7.5 M (-0.01 %) |
| Sep 12 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 41.00 | 200,350 | 8,214,350 | 7,487,404 | 7.7 M to 7.5 M (-2.61 %) |
| Jun 16 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 2,475,191 | 3.5 M to 2.5 M (-28.78 %) |
| May 19 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 3,475,191 | 4.5 M to 3.5 M (-22.35 %) |
| May 19 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Gift | G | 0.00 | 1,708 | 0 | 163,996 | 165.7 K to 164 K (-1.03 %) |
| May 19 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Gift | G | 0.00 | 50,000 | 0 | 165,704 | 215.7 K to 165.7 K (-23.18 %) |
| Apr 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 4,475,191 | 6.5 M to 4.5 M (-30.89 %) |
| Apr 03 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 850,000 | 0 | 7,687,754 | 8.5 M to 7.7 M (-9.96 %) |
| Mar 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 28.73 | 10,900 | 313,146 | 146,208 | 157.1 K to 146.2 K (-6.94 %) |
| Mar 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 27.69 | 7,279 | 201,526 | 157,108 | 164.4 K to 157.1 K (-4.43 %) |
| Mar 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 26.95 | 27,115 | 730,803 | 164,387 | 191.5 K to 164.4 K (-14.16 %) |
| Mar 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 25.50 | 1,000,000 | 25,500,000 | 285,713 | 1.3 M to 285.7 K (-77.78 %) |
| Mar 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 25.50 | 1,000,000 | 25,500,000 | 6,475,191 | 7.5 M to 6.5 M (-13.38 %) |
| Feb 09 2017 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 35.28 | 1,000,000 | 35,275,000 | 4,453,753 | 5.5 M to 4.5 M (-18.34 %) |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 11,250,000 | 0 | 0 | |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 35,750,000 | 0 | 0 | |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 3,048,780 | 0 | 3,048,780 | 0 to 3 M |
| Feb 03 2017 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 9,688,344 | 0 | 10,230,349 | 542 K to 10.2 M (+1,787.50 %) |
| Dec 16 2016 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 7,475,191 | 9.5 M to 7.5 M (-21.11 %) |
| Dec 01 2016 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 850,000 | 0 | 8,537,754 | 9.4 M to 8.5 M (-9.05 %) |
| Nov 16 2016 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 19.36 | 1,000,000 | 19,360,000 | 1,285,713 | 2.3 M to 1.3 M (-43.75 %) |
| Nov 16 2016 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 19.36 | 1,000,000 | 19,360,000 | 9,475,191 | 10.5 M to 9.5 M (-9.55 %) |
| Nov 07 2016 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 10,475,191 | 12.5 M to 10.5 M (-16.03 %) |
| Aug 19 2016 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 2,892,916 | 3.9 M to 2.9 M (-25.69 %) |
| May 18 2016 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 31.25 | 850,000 | 26,562,500 | 3,892,916 | 4.7 M to 3.9 M (-17.92 %) |
| Apr 15 2016 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,200,000 | 0 | 5,453,753 | 6.7 M to 5.5 M (-18.03 %) |
| Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 40,290 | 0 | 40,290 | 0 to 40.3 K |
| Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 40,290 | 0 | 40,290 | 0 to 40.3 K |
| Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 40,290 | 0 | 40,290 | 0 to 40.3 K |
| Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 220,387 | 0 | 0 | 220.4 K to 0 (-100.00 %) |
| Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 220,387 | 0 | 220,387 | 0 to 220.4 K |
| Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 739,306 | 0 | 6,653,753 | 7.4 M to 6.7 M (-10.00 %) |
| Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 15,986 | 0 | 65,227 | 49.2 K to 65.2 K (+32.46 %) |
| Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 15,986 | 0 | 65,226 | 49.2 K to 65.2 K (+32.47 %) |
| Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 109,832 | 0 | 0 | 109.8 K to 0 (-100.00 %) |
| Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 109,832 | 0 | 109,832 | 0 to 109.8 K |
| Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,700,000 | 0 | 4,742,916 | 6.4 M to 4.7 M (-26.39 %) |
| Nov 05 2015 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,500,000 | 0 | 0 | |
| Nov 05 2015 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 32,500,000 | 0 | 0 | |
| Nov 05 2015 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 1,496,598 | 0 | 1,496,598 | 0 to 1.5 M |
| Nov 05 2015 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 8,843,537 | 0 | 9,387,754 | 544.2 K to 9.4 M (+1,625.00 %) |
| Aug 19 2015 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 41,663,168 | 0 | 0 | |
| Aug 19 2015 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 11,903,763 | 0 | 12,475,191 | 571.4 K to 12.5 M (+2,083.16 %) |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 21,910 | 0 | 49,241 | 27.3 K to 49.2 K (+80.17 %) |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 21,910 | 0 | 49,240 | 27.3 K to 49.2 K (+80.17 %) |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 150,546 | 0 | 0 | 150.5 K to 0 (-100.00 %) |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 150,546 | 0 | 150,546 | 0 to 150.5 K |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,330,157 | 0 | 6,442,916 | 8.8 M to 6.4 M (-26.56 %) |
| Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 9,403 | 0 | 27,331 | 17.9 K to 27.3 K (+52.45 %) |
| Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 9,402 | 0 | 27,330 | 17.9 K to 27.3 K (+52.44 %) |
| Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 64,607 | 0 | 0 | 64.6 K to 0 (-100.00 %) |
| Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 64,607 | 0 | 64,607 | 0 to 64.6 K |
| Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 8,773,073 | 9.8 M to 8.8 M (-10.23 %) |
| May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,328,502 | 0 | 0 | |
| May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,833,333 | 0 | 0 | |
| May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 30,000,000 | 0 | 0 | |
| May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 241,545 | 0 | 7,393,059 | 7.2 M to 7.4 M (+3.38 %) |
| May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 1,424,242 | 0 | 7,151,514 | 5.7 M to 7.2 M (+24.87 %) |
| May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 5,454,545 | 0 | 5,727,272 | 272.7 K to 5.7 M (+2,000.00 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 295,194 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,499,999 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 32,500,000 | 0 | 0 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 93,712 | 0 | 11,681,008 | 11.6 M to 11.7 M (+0.81 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 793,650 | 0 | 11,587,296 | 10.8 M to 11.6 M (+7.35 %) |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 10,317,457 | 0 | 10,793,646 | 476.2 K to 10.8 M (+2,166.67 %) |
Page: 1